Anesthesiology Commons^™

Safety Culture In Cardiac Surgical Teams: Data From Five Programs And National Surgical Comparison., Jill A Marsteller, Mei Wen, Yea-Jen Hsu, Laura C Bauer, Nanette M. Schwann M.D., Christopher J Young, Juan A Sanchez, Nicole A Errett, Ayse P Gurses, David A Thompson, Joyce A Wahr, Elizabeth A Martinez

Nanette M Schwann MD

BACKGROUND: Little is known about safety culture in the area of cardiac surgery as compared with other types of surgery. The unique features of cardiac surgical teams may result in different perceptions of patient safety and patient safety culture.

METHODS: We measured and described safety culture in five cardiovascular surgical centers using the Hospital Survey on Patient Safety Culture, and compared the data with the Agency for Healthcare Research and Quality (AHRQ) 2010 comparative database in surgery and anesthesiology (all types). We reported mean scores, standard deviations, and percent positive responses for the two single-item measures and 12 patient safety …

Percutaneous Dilational Tracheostomy: Anesthetic Considerations For A Growing Trend, Nan Schwann

Nanette M Schwann MD

No abstract provided.

Perturbations In Laboratory Values After Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass, Patrick Möhnle, Nan Schwann, William Vaughn, Michael Snabes, Winnie Lau, Jack Levin, Nancy Nussmeier

Nanette M Schwann MD

No abstract provided.

Hormone Replacement Therapy Is Safe In Women Undergoing Coronary Artery Bypass Grafting, Nancy Nussmeier, Christina Mora-Mangano, Manuel Fontes, Nan Schwann, Dennis Mangano, Ischemia Research Education Foundation, Multicenter Study Perioperative Ischemia Research Group

Nanette M Schwann MD

No abstract provided.

Off Pump Coronary Artery Bypass Surgery Outcomes And Management, Aras Ali, Patrick Möhnle, Nan Schwann

Nanette M Schwann MD

No abstract provided.

Intrathecal Morphine For Off-Pump Coronary Aartery Bypass Grafting, Samuel Metz, Nan Schwann, Wael Hassanein, Brian Yuskevich, Todd Nixon

Nanette M Schwann MD

No abstract provided.

The Effect Of Beta-Blocker Dosing Strategy On Regulation Of Perioperative Heart Rate And Clinical Outcomes In Patients Undergoing Vascular Surgery: A Randomized Comparison, Paul Cesanek, Nan Schwann, Eric Wilson, Sallie Urffer, Crystal Maksimik, Susan Nabhan, Joseph Ottinger, Jeff Astbury, Yufei Xiang, Martin Matsumura

Nanette M Schwann MD

No abstract provided.

No Pain, Much Gain?, Nan Schwann, Mark Chaney

Nanette M Schwann MD

No abstract provided.

Pulmonary-Artery Catheters In High-Risk Surgical Patients, Nan Schwann, Dennis Mangano, Multicenter Study Perioperative Ischemia Research Group

Nanette M Schwann MD

No abstract provided.

Evaluation Of Transesophageal Atrial Pacing In The Prone And Lateral Positions, Nan Schwann, David Maguire, Jonathan Roth, Stephen Mcnulty, Anthony Saouaf

Nanette M Schwann MD

No abstract provided.

Predictive Value Of The National Institutes Of Health Stroke Scale And The Mini-Mental State Examination For Neurologic Outcome After Coronary Artery Bypass Graft Surgery, Nancy Nussmeier, Miao Yinghui, Gary Roach, Richard Wolman, Christina Mora-Mangano, Mark Fox, Andrea Szekely, Concezione Tommasino, Nan Schwann, Dennis Mangano

Nanette M Schwann MD

No abstract provided.

Variation In Local Institutional Review Board Evaluations Of A Multicenter Patient Safety Study, David Thompson, Nancy Kass, Christine Hozmueller, Jill Marsteller, Elizabeth Martinez, Ayse Gurses, Mar Kanchuger, Nan Schwann, Charles Gibson, Lauer Bauer, Peter Pronovost

Nanette M Schwann MD

No abstract provided.

A Case Of Artifactual Rebreathing, Nan Schwann, David Maguire, Graig Smith

Nanette M Schwann MD

No abstract provided.

In Response, Nan Schwann, Zak Hillel, Paul Barash

Nanette M Schwann MD

No abstract provided.

Does Off-Pump Coronary Artery Bypass Reduce The Incidence Of Clinically Evident Renal Dysfunction After Multivessel Myocardial Revascularization?, Nan Schwann, Jay Horrow, Michael Strong, Dmitri Chamchad, Albert Guerraty, Andrew Wechsler

Nanette M Schwann MD

No abstract provided.

Failing To Reject The Null Hypothesis Does Not Mean That The Null Hypothesis Is True, Nan Schwann, Jay Horrow

Nanette M Schwann MD

No abstract provided.

Lack Of Effectiveness Of The Pulmonary Artery Catheter In Cardiac Surgery, Nanette Schwann

Nanette M Schwann MD

Lack of effectiveness of the pulmonary artery catheter in cardiac surgery. Schwann NM, Hillel Z, Hoeft A, Barash P, Möhnle P, Miao Y, Mangano DT. Source Allentown Anesthesia Associates and the Leigh Valley Healthcare Network, Department of Anesthesiology, 1245 Cedar Crest Blvd., Suite 300, Allentown, PA 18103, USA. schwann@mac.com Abstract BACKGROUND: The pulmonary artery catheter (PAC) continues to be used for monitoring of hemodynamics in patients undergoing coronary artery bypass graft (CABG) surgery despite concerns raised in other settings regarding both effectiveness and safety. Given the relative paucity of data regarding its use in CABG patients, and given entrenched practice …

A Retrospective Review Of Clinical International Normalized Ratio Results And Their Implications, Thomas Radmer, Moawia Kassab, James Glore

Thomas W Radmer

Warfrin is a key element in therapy for atrial fibrillation, deep venous thrombosis (DVT), stroke (cerebrovascular accident and cardiac valve replacement . The authors searced 16,017 active clinical charts for active patients of record for the years 2009-2010. The authors found that 1.96 percent of total Marquette University Dental Clinic patients had a history of warfrin use. INR values for a significant number of dental patients are not within the therapeutic range for their medical conditions. The patients physcian was contacted for warfrin dose regulation prior to invasive dental procedures.

Acceptance Of An Abo-Incompatible Mismatched (Ab(+) To O(+)) Liver Allograft With The Use Of Daclizumab And Mycophenolate Mofetil, W. Fang, John Saltzman, Sarah Rososhansky, Gyongyi Szabo, Stephen Heard, Barbara Banner, Ravi Chari, Eliezer Katz

Gyongyi Szabo

Liver allograft survival rates of 50% to 60% are reported in blood group A, group B, group O (ABO)-incompatible mismatched grafts even when aggressive immunosuppressive protocols, including plasmapheresis, OKT(3), cyclophosphamide, cyclosporine, prostaglandin E(1), and steroids, are used. A 59-year-old woman, blood type O(+), required emergency retransplantation posttransplantation day 2 because of primary nonfunction of the liver allograft. A blood type AB(+) allograft was used. Induction immunosuppressive therapy included tacrolimus, mycophenolate mofetil, OKT(3) (muromonab-CD(3)), steroids, and prostaglandin E(1). In addition, plasmapheresis was performed daily for 9 days. OKT(3) and prostaglandin E(1) were also discontinued postoperative day 9. Biopsy-proven acute cellular rejection …